PHIO PHARMACEUTICALS CORP. Increase (Decrease) in Restricted Cash
PHIO PHARMACEUTICALS CORP. (PHIO) reported Increase (Decrease) in Restricted Cash of -$3.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2015-03-30
- PHIO PHARMACEUTICALS CORP. increase (decrease) in restricted cash for fiscal 2013 was -$3.00K.
| Period end | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 117 month |
|---|---|---|
| 2013-12-31 | -$3.00K 10-K · filed 2015-03-30 | |
| 2012-09-30 | $53.00K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |